Rituximab versus cyclophosphamide as first steroid-sparing agent in childhood frequently relapsing and steroid-dependent nephrotic syndrome.
Pediatr Nephrol
; 35(8): 1445-1453, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32337638
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cyclophosphamide
/
Rituximab
/
Immunosuppressive Agents
/
Nephrotic Syndrome
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
Pediatr Nephrol
Journal subject:
NEFROLOGIA
/
PEDIATRIA
Year:
2020
Document type:
Article
Country of publication:
Germany